Investing

Cybin : CYBN

CYBN

Stock Data

$0.00

$0.00 (0.00%)

Asset Type

Common Stock

Exchange

NYSE MKT

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Cybin Inc is a trailblazer in the biopharmaceutical industry, focusing on the development of psychedelic-based treatments. With a robust pipeline, including CYB003 for major depressive and alcohol use disorders, CYB004 for generalized anxiety, and CYB005 for neuroinflammation, Cybin is at the forefront of exploring the therapeutic potential of psychedelics. Additionally, its EMBARK model offers a unique psychological support framework, enhancing the healing process. Based in Toronto, Canada, Cybin is committed to unlocking new pathways to mental wellness.

All Cybin Articles

3 Articles

Andrew Dupont | Nov 29, 2023 at 8:35 AM EST

6 Popular Penny Stocks on Robinhood – Are They Good Investments?

Penny stocks have become a popular thing to put a couple of bucks into and see what happens. Worst case…

Chris Lange | Jan 25, 2022 at 7:35 AM EST

5 Psychedelic Therapeutics Decisions Coming in 2022

Here is a look of a few of the biggest clinical trial and FDA updates in regards to psychedelics to…

Paul Ausick | Sep 8, 2021 at 12:39 PM EDT

Time to Buy the Magic Stocks? Magic Mushrooms, That Is.

Here's a quick look at six publicly traded companies developing ways to use psychedelics to treat mental health issues.